SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000892569-99-002475
Filing Date
1999-09-17
Accepted
1999-09-17 00:00:00
Documents
3
Period of Report
1999-09-14
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 5134
2 PRESS RELEASE - LUPUS DRUG EX-99.1 5556
3 PRESS RELEASE - RESTRUCTURING DATED SEPT. 14, 1999 EX-99.2 8234
  Complete submission text file 0000892569-99-002475.txt   20609
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 99713355
SIC: 2836 Biological Products, (No Diagnostic Substances)